Calcium-channel blockers and cancer

Lancet. 1996 Oct 26;348(9035):1165-6; author reply 1167. doi: 10.1016/s0140-6736(05)65295-6.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antihypertensive Agents / adverse effects
  • Calcium Channel Blockers / adverse effects*
  • Humans
  • Neoplasms / chemically induced*
  • Neoplasms / epidemiology

Substances

  • Antihypertensive Agents
  • Calcium Channel Blockers